BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35832305)

  • 1. Treatment with Herbal Formula Extract in the hSOD1
    Yang EJ; Lee SH; Cai M
    Mediators Inflamm; 2022; 2022():4754732. PubMed ID: 35832305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bojungikgi-tang Improves Muscle and Spinal Cord Function in an Amyotrophic Lateral Sclerosis Model.
    Cai M; Lee SH; Yang EJ
    Mol Neurobiol; 2019 Apr; 56(4):2394-2407. PubMed ID: 30030751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desloratadine alleviates ALS-like pathology in hSOD1
    Lu J; He AX; Jin ZY; Zhang M; Li ZX; Zhou F; Ma L; Jin HM; Wang JY; Shen X
    Acta Pharmacol Sin; 2024 May; 45(5):926-944. PubMed ID: 38286832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model.
    Cai M; Yang EJ
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic.
    Martin LJ; Adams DA; Niedzwiecki MV; Wong M
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1
    Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA
    Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of RAGE inhibition on the progression of the disease in hSOD1
    Liu L; Killoy KM; Vargas MR; Yamamoto Y; Pehar M
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00636. PubMed ID: 32776498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory Effects of a Novel Herbal Extract in the Muscle and Spinal Cord of an Amyotrophic Lateral Sclerosis Animal Model.
    Lee SH; Cai M; Yang EJ
    Front Neurosci; 2021; 15():743705. PubMed ID: 34858128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1
    Lee JD; McDonald TS; Fung JNT; Woodruff TM
    Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis.
    Huo D; Liang W; Wang D; Liu Q; Wang H; Wang Y; Zhang C; Cong C; Su X; Tan X; Zhang W; Han L; Zhang D; Wang M; Feng H
    Neuropharmacology; 2024 Apr; 247():109812. PubMed ID: 38218579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Lee JD; Kamaruzaman NA; Fung JN; Taylor SM; Turner BJ; Atkin JD; Woodruff TM; Noakes PG
    J Neuroinflammation; 2013 Sep; 10():119. PubMed ID: 24067070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Re Attenuates Neuroinflammation in a Symptomatic ALS Animal Model.
    Cai M; Yang EJ
    Am J Chin Med; 2016; 44(2):401-13. PubMed ID: 27080948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
    López-González R; Kunckles P; Velasco I
    Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of complement C5a-C5a
    Lee JD; Kumar V; Fung JN; Ruitenberg MJ; Noakes PG; Woodruff TM
    Br J Pharmacol; 2017 Apr; 174(8):689-699. PubMed ID: 28128456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS).
    Lee NY; Kim Y; Ryu H; Kang YS
    Biochem Biophys Res Commun; 2017 Jan; 483(1):135-141. PubMed ID: 28043791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
    Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
    Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.
    Gertz B; Wong M; Martin LJ
    J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.
    Meister S; Storck SE; Hameister E; Behl C; Weggen S; Clement AM; Pietrzik CU
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1112-21. PubMed ID: 25853911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.